Infectious Diseases
Latest News
New Infant RSV Antibody Treatment Shows Strong Results
Babies who received the new preventive treatment for RSV shortly after birth were 90% less likely to be severely sickened.
Commentary
COVID-19 Is a Very Weird Virus
COVID may cause immune system dysfunction that puts patients at risk for autoimmunity.
Latest News
Mixing Paxlovid With Specific Immunosuppressants Risks Serious Adverse Reactions
The EMA has warned that Paxlovid should only be administered alongside tacrolimus, ciclosporin, everolimus, or sirolimus if their blood levels can...
Latest News
Long COVID Has Caused Thousands of US Deaths: New CDC Data
The risk for long COVID fatalities remains elevated for at least 6 months for people with milder acute infections and for at least 2 years in...
Latest News
Hospital Adverse Events Rise After Private Equity Acquisition
Notably, the incidence of surgical site infections increased from 10.8 per 10,000 hospitalizations before acquisition to 21.6 per 10,000...
Latest News
COVID Strain JN.1 Is Now a ‘Variant of Interest,’ WHO Says
The variant accounted for an estimated 21% of cases for the 2-week period ending December 9, up from 8% during the 2 weeks prior.
Latest News
Systemic Bias in AI Models May Undermine Diagnostic Accuracy
Clinicians’ accuracy decreased by 11.3% after viewing systematically biased AI model predictions compared with baseline.
From the Journals
COVID vaccines lower risk of serious illness in children
“The findings in this report support the recommendation for COVID-19 vaccination for all children aged ≥6 months and highlight the importance of...
News from the FDA/CDC
New CDC advisory once again flags BA.2.86 COVID variant
The variant accounted for nearly 9% of cases during the 2-week period ending Nov. 25, up from 3% during the previous 2 weeks.
Conference Coverage
AI tool perfect in study of inflammatory diseases
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
From the Journals
Piperacillin-tazobactam poses no renal risk in adults with sepsis
“These data should offer solace that if the choice is made to use piperacillin-tazobactam, there is not an increased risk of AKI.”